FDA Inspection 1119996 — Risal Djohan MD

Risal Djohan MD — FEI 3015859202

The FDA completed an inspection of Risal Djohan MD on Feb 7, 2020 in Cleveland, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 7, 2020
Fiscal Year
2020
Product Type
Devices
Project Area
Bioresearch Monitoring
Location
Cleveland, OH (United States)

Additional details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.